» Articles » PMID: 36211536

Evaluation of a New Emergency Department Avoidance Model of Care, the Cancer Urgent Assessment Clinic, in Response to the COVID-19 Pandemic

Overview
Specialty Critical Care
Date 2022 Oct 10
PMID 36211536
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The Cancer Urgent Assessment Clinic (CUAC) was an emergency department (ED) avoidance/unscheduled model of care implemented in response to the COVID-19 pandemic. The aim was to reduce the risk of COVID-19 exposure and infection by providing an alternative to ED for cancer patients while undergoing anticancer treatments.

Methods: The clinic incorporated a telephone triage process and face-to-face appointments 8am to 8pm, 7 days per week. CUAC operated between 23 March '20 and 31 July '20, led by a nurse practitioner candidate, oncology registrars, cancer nurse specialists, and overseen by oncology consultants. Evaluation followed a mixed-methods approach through (1) analysis of CUAC patient data, (2) comparison of ED cancer patient presentation data from a previous period (23 March 2019-31 July 2019), and (3) a patient survey.

Results: In total, 400 patients were telephone triaged via CUAC, with 166 recorded as having avoided ED. There was a reduction in the number of cancer patient admissions to the ED short stay unit during the clinic period compared with the same time-period in 2019: 130 vs. 234, associated with 615 fewer hours. Patient satisfaction was positive particularly regarding ease of access, time to treatment, confidence in assessment and treatment of cancer-related concerns, and likelihood of presenting to hospital when unwell during the pandemic.

Discussion: While initially being implemented to reduce the risk of COVID-19 exposure, this evaluation demonstrated the CUAC model was an efficient and potentially cost-saving model of care for the management of cancer patients with mild to moderate severity of disease and treatment-related concerns.

Citing Articles

Cross-sectional study to evaluate patients' medication management with a new model of care: incorporating a pharmacist into a community specialist palliative care telehealth service.

M Chess-Williams L, M Broadbent A, Hattingh L BMC Palliat Care. 2024; 23(1):172.

PMID: 39010021 PMC: 11251105. DOI: 10.1186/s12904-024-01508-1.


Provision of acute oncology services in the UK: data from the Society for Acute Medicine Benchmarking Audit 2022 (SAMBA22).

Kulkarni S, Knight T, Cooksley T, Marshall E, Patel N, Selvaratnam R Clin Med (Lond). 2023; 23(6):571-581.

PMID: 38065597 PMC: 11046619. DOI: 10.7861/clinmed.2023-0251.


COVID-19 Patients' Medication Management during Transition of Care from Hospital to Virtual Care: A Cross-Sectional Survey and Audit.

Hattingh H, Edmunds C, Buksh S, Cronin S, Gillespie B Pharmacy (Basel). 2023; 11(5).

PMID: 37888502 PMC: 10610024. DOI: 10.3390/pharmacy11050157.


Medication management of COVID-19 patients during transition to virtual models of care: a qualitative study.

Hattingh H, Edmunds C, Gillespie B J Pharm Policy Pract. 2023; 16(1):127.

PMID: 37880768 PMC: 10598939. DOI: 10.1186/s40545-023-00633-1.


Evaluation of the Impact of the Urgent Cancer Care Clinic on Emergency Department Visits, Primary Care Clinician Visits, and Hospitalizations in Winnipeg, Manitoba.

Galloway K, Lambert P, Bow E, Czaykowski P, Fatoye T, Goldenberg B Curr Oncol. 2023; 30(7):6771-6785.

PMID: 37504356 PMC: 10378500. DOI: 10.3390/curroncol30070496.


References
1.
Al-Shamsi H, Alhazzani W, Alhuraiji A, Coomes E, Chemaly R, Almuhanna M . A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020; 25(6):e936-e945. PMC: 7288661. DOI: 10.1634/theoncologist.2020-0213. View

2.
McKenzie H, Hayes L, White K, Cox K, Fethney J, Boughton M . Chemotherapy outpatients' unplanned presentations to hospital: a retrospective study. Support Care Cancer. 2010; 19(7):963-9. DOI: 10.1007/s00520-010-0913-y. View

3.
Vandyk A, Harrison M, Macartney G, Ross-White A, Stacey D . Emergency department visits for symptoms experienced by oncology patients: a systematic review. Support Care Cancer. 2012; 20(8):1589-99. DOI: 10.1007/s00520-012-1459-y. View

4.
Pugh A, Rogerson H, Cosh H, Hart J, Williams H, Jenkins C . Acute oncology: a developing sub-specialty. Br J Nurs. 2015; 24(16):S18-25. DOI: 10.12968/bjon.2015.24.Sup16.S18. View

5.
Di Ciaccio P, McCaughan G, Trotman J, Ho P, Cheah C, Gangatharan S . Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Intern Med J. 2020; 50(6):667-679. DOI: 10.1111/imj.14859. View